Prediction of schizophrenia using MAOA-uVNTR polymorphism: A case-control study

Area of Science:

• Neuroscience
• Genetics
• Psychiatry

Background:

• Schizophrenia is linked to dopamine system dysregulation, influenced by the serotonin pathway.
• Dopamine and serotonin levels are modulated by specific transporters and enzymes.
• This study investigates four key genetic polymorphisms: DAT-VNTR, 5-HTTLPR, MAOA-uVNTR, and COMT Val158Met.

Purpose of the Study:

• To determine the frequencies of DAT-VNTR, 5-HTTLPR, MAOA-uVNTR, and COMT Val158Met polymorphisms in healthy individuals and schizophrenia patients.
• To assess the association between these polymorphisms and the risk of developing schizophrenia.

Main Methods:

• Genotyping of polymorphisms using polymerase chain reaction (PCR) and gel electrophoresis.
• Analysis of genotype distributions in 314 healthy volunteers and 306 schizophrenia patients.
• Statistical analysis including Chi-square tests, Mann-Whitney test, and logistic regression for association and prediction.

Main Results:

• A significant association was found between MAOA-uVNTR polymorphism and schizophrenia (P = 0.010).
• Differences in genotype distribution were observed for COMT Val158Met in females and DAT-VNTR overall (P = 0.021, P = 0.028).
• Logistic regression achieved 80.45% accuracy in classifying participants, highlighting predictive potential.

Conclusions:

• MAOA-uVNTR polymorphism is significantly associated with schizophrenia.
• Observed variations in COMT Val158Met and DAT-VNTR support the role of dopamine system components in schizophrenia pathogenesis.
• These findings contribute to understanding the genetic underpinnings of schizophrenia.